Join
Live feed
·
PRReleasevia Quantisnow
Vyant Bio Inc. logo

Vyant Bio Announces Stockholder Approval of Proposed Asset Sale; 64,110 Votes Needed to Approve Plan of Dissolution; and Adjournment of Special Meeting of Stockholders

ByQuantisnow·Wall Street's wire, on your screen.
VYNT· Vyant Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYNT (Vyant Bio Inc.) and more on Quantisnow.